Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: Studies of a retired NFL player and of a man with FTD and a severe head injury

Translational Psychiatry

Volumn 4, Issue 9, 2014, Pages

  Mitsis, E M ^a,b   Riggio, S ^a,b   Kostakoglu, L ^a   Dickstein, D L ^a   Machac, J ^a   Delman, B ^a   Goldstein, M ^a   Jennings, D ^c   D'Antonio, E ^a   Martin, J ^a   Naidich, T P ^a   Aloysi, A ^a   Fernandez, C ^a,b   Seibyl, J ^c   DeKosky, S T ^d   Elder, G A ^a,b   Marek, K ^c   Gordon, W ^a   Hof, P R ^a   Sano, M ^a,b   Gandy, S ^a,b   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLORBETAPIR F 18; ANILINE DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AMYLOID PLAQUE; ARACHNOID CYST; ARTICLE; CASE REPORT; CONCUSSION; DIAGNOSTIC ACCURACY; EYE MOVEMENT; FOOTBALL; FRONTOTEMPORAL DEMENTIA; HEAD INJURY; HUMAN; INJURY SEVERITY; LIGAND BINDING; MALE; MEMORY DISORDER; MIDDLE AGED; MOLECULAR IMAGING; MOTOR DYSFUNCTION; MUSCLE TONE; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; SHORT TERM MEMORY; SUBDURAL HEMATOMA; TAUOPATHY; TRAUMATIC BRAIN INJURY; BRAIN; BRAIN CONCUSSION; BRAIN INJURY; COMPLICATION; DIAGNOSTIC USE; SCINTISCANNING;

AGED; ANILINE COMPOUNDS; BRAIN; BRAIN CONCUSSION; BRAIN INJURY, CHRONIC; CRANIOCEREBRAL TRAUMA; ETHYLENE GLYCOLS; FOOTBALL; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; PLAQUE, AMYLOID; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TAUOPATHIES;

EID: 84918535750     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.91     Document Type: Article

References (39)

1. Gorwood P, Bouvard M, Mouren-Simeoni MC, Kipman A, Ades J. Genetics and anorexia nervosa: a review of candidate genes. Psychiatr Genet 1998; 8: 1-12.
2. Ben-Dor DH, Laufer N, Apter A, Frisch A, Weizman A. Heritability, genetics and association findings in anorexia nervosa. Isr J Psychiatry Relat Sci 2002; 39: 262-270.
3. Stoving RK, Andries A, Brixen K, Flyvbjerg A, Horder K, Frystyk J. Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa. J Psychiatr Res 2009; 43: 671-679.
4. de Krom M, Bauer F, Collier D, Adan RA, la Fleur SE. Genetic variation and effects on human eating behavior. Annu Rev Nutr 2009; 29: 283-304.
5. Bergen AW, van den Bree MB, Yeager M, Welch R, Ganjei JK, Haque K et al. Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry 2003; 8: 397-406.
6. Bulik CM, Slof-Op't Landt MC, van Furth EF, Sullivan PF. The genetics of anorexia nervosa. Annu Rev Nutr 2007; 27: 263-275.
7. Hinney A, Friedel S, Remschmidt H, Hebebrand J. Genetic risk factors in eating disorders. Am J Pharmacogenomics 2004; 4: 209-223.
8. Tozzi F, Bulik CM. Candidate genes in eating disorders. Curr Drug Targets CNS Neurol Disord 2003; 2: 31-39.
9. Pinheiro AP, Bulik CM, Thornton LM, Sullivan PF, Root TL, Bloss CS et al. Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 1070-1080.
10. Root TL, Szatkiewicz JP, Jonassaint CR, Thornton LM, Pinheiro AP, Strober M et al. Association of candidate genes with phenotypic traits relevant to anorexia nervosa. Eur Eat Disord Rev 2011; 19: 487-493.
11. Costanza, A., Weber, K., Gandy, S., Bouras, C., Hof, P.R., Giannakopoulos, P., Canuto, A., Review: Contact sport-related chronic traumatic encephalopathy in the elderly: Clinical expression and structural substrates, Neuropathology and Applied Neurobiology, 37(6), 2011, pp:570-584
12. Boraska V, Franklin CS, Floyd JAB, Thornton LM, Huckins LM, Southam L et al. A genome-wide association study of anorexia nervosa. Mol Psychiatry advanced online publication, 11 February 2014 .
13. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. American Psychiatric Press: Washington DC, USA, 2000.
14. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004; 161: 2215-2221.
15. Swinbourne JM, Touyz SW. The co-morbidity of eating disorders and anxiety disorders: a review. Eur Eat Disord Rev 2007; 15: 253-274.
16. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 2009; 15: 509-518.
17. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
18. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L et al. A survey of genetic human cortical gene expression. Nat Genet 2007; 39: 1494-1499.
19. Nakata K, Lipska BK, Hyde TM, Ye T, Newburn EN, Morita Y et al. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci USA 2009; 106: 15873-15878.
20. Kleinman JE, Law AJ, Lipska BK, Hyde TM, Ellis JK, Harrison PJ et al. Genetic neuropathology of schizophrenia: new approaches to an old question, and new uses for post mortem human brains. Biol Psychiatry 2011; 69: 140-145.
21. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol Psychiatry 2006; 60: 650-658.
22. Deep-Soboslay A, Akil M, Martin CE, Bigelow LB, Herman MM, Hyde TM et al. Reliability of psychiatric diagnosis in postmortem research. Biol Psychiatry 2005; 57: 96-101.
23. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
24. Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013; 10: 5-6.
25. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.
26. Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA et al. Genomewide association study of obsessive-compulsive disorder. Mol Psychiatry 2013; 18: 788-798.
27. Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 2007; 3: 1724-1735.
28. Kortenhorst MS, Wissing MD, Rodriguez R, Kachhap SK, Jans JJ, Van der Groep P et al. Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors. Epigenetics 2013; 8: 907-920.
29. Gratacos M, Costas J, de Cid R, Bayes M, Gonzalez JR, Baca-Garcia E et al. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 808-816.
30. Brown KM, Bujac SR, Mann ET, Campbell DA, Stubbins MJ, Blundell JE. Further evidence of association of OPRD1 & HTR1D polymorphisms with susceptibility to anorexia nervosa. Biol Psychiatry 2007; 61: 367-373.
31. Meijer H, de Graaff E, Merckx DM, Jongbloed RJ, de Die-Smulders CE, Engelen JJ et al. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet 1994; 3: 615-620.
32. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 2011; 60: 2624-2634.
33. Marschner K, Kollmann K, Schweizer M, Braulke T, Pohl S. A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism. Science 2011; 333: 87-90.
34. Plante M, Claveau S, Lepage P, Lavoie EM, Brunet S, Roquis D et al. Mucolipidosis II: a single causal mutation in the N-Acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population. Clin Genet 2008; 73: 236-244.
35. Wahr PA, Michele DE, Metzger JM. Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes. Proc Natl Acad Sci USA 1999; 96: 11982-11985.
36. Debril MB, Gelman L, Fayard E, Annicotte JS, Rocchi S, Auwerx J. Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. J Biol Chem 2004; 279: 16677-16686.
37. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005; 10: 309-322.
38. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004; 101: 2173-2178.
39. Trace SE, Baker JH, Penas-Lledo E, Bulik CM. The genetics of eating disorders. Annu Rev Clin Psychol 2013; 9: 589-620.